These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26239566)

  • 21. Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.
    Foukas AF; Deshmukh NS; Grimer RJ; Mangham DC; Mangos EG; Taylor S
    J Bone Joint Surg Br; 2002 Jul; 84(5):706-11. PubMed ID: 12188489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma.
    Himelstein BP; Asada N; Carlton MR; Collins MH
    Med Pediatr Oncol; 1998 Dec; 31(6):471-4. PubMed ID: 9835898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis on the association of HER-2 overexpression with prognosis in human osteosarcoma.
    Li YG; Geng X
    Eur J Cancer Care (Engl); 2010 May; 19(3):313-6. PubMed ID: 19709164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
    J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
    Fu Y; Lan T; Cai H; Lu A; Yu W
    Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma.
    Felx M; Guyot MC; Isler M; Turcotte RE; Doyon J; Khatib AM; Leclerc S; Moreau A; Moldovan F
    Clin Sci (Lond); 2006 Jun; 110(6):645-54. PubMed ID: 16417466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.
    Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH
    Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
    Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
    Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of pathologic fracture in patients with high grade localized osteosarcoma: a systemic review and meta-analysis of cohort studies.
    Sun L; Li Y; Zhang J; Li H; Li B; Ye Z
    J Orthop Res; 2015 Jan; 33(1):131-9. PubMed ID: 25231396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
    Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
    J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases participate in osteosarcoma invasion.
    Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
    J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
    Chen D; Zhang YJ; Zhu KW; Wang WC
    Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis.
    Ren W; Gu G
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26503016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
    Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
    Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucosamine sulfate suppresses the expression of matrix metalloproteinase-3 in osteosarcoma cells in vitro.
    Pohlig F; Ulrich J; Lenze U; Mühlhofer HM; Harrasser N; Suren C; Schauwecker J; Mayer-Kuckuk P; von Eisenhart-Rothe R
    BMC Complement Altern Med; 2016 Aug; 16(1):313. PubMed ID: 27562075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
    Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
    Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma.
    Feng J; Lan R; Cai G; Lin J; Wang X; Lin J; Han D
    J Orthop Surg Res; 2016 Nov; 11(1):150. PubMed ID: 27881153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.